Abstract: G-protein-coupled receptor (GPCR) ligands impart differing degrees of signaling in the G-protein and arrestin pathways, in phenomena called "biased signaling". However, the mechanism underlying the biased signaling of GPCRs is still unclear,although crystal structures of GPCRs bound to the Gprotein or arrestin are available.I nt his study,w eo bserved the NMR signals from methionine residues of the m-opioid receptor (mOR) in the balanced-and biased-ligand-bound states.Wefound that the intracellular cavity of mOR exists in an equilibrium between closed and multiple open conformations with coupled conformational changes on the transmembrane helices 3, 5, 6, and 7, and that the population of eacho pen conformation determines the G-protein-and arrestin-mediated signaling levels in each ligand-bound state.T hese findings provideinsight into the biased signaling of GPCRs and will be helpful for development of analgesics that stimulate mOR with reduced tolerance and dependence.
G-protein-coupled receptors (GPCRs) are one of the largest membrane protein families in eukaryotes,a nd more than 30 %o fmodern drugs target GPCRs.D rugs binding to GPCRs lead to the activation of signal transduction mediated by Gproteins.F urthermore,t he activated GPCRs are phosphorylated by GPCR kinases (GRKs), and the phosphorylated GPCRs stimulate G-protein-independent signal transduction mediated by arrestin.
GPCR ligands promote differing degrees of signaling in the G-protein and arrestin pathways,i np henomena called "functional selectivity" or "biased signaling", [1] and the ligands that promote both of the signaling pathways and those that preferably promote one of the signaling pathways are referred to as "balanced ligands" and "biased ligands", respectively.I nt he case of the m-opioid receptor (mOR), [2] ac lass AGPCR stimulated by various opioid drugs,s uch as morphine,s timulation by TRV130 [3] elicits signaling through Gi, the inhibitory Gprotein for adenylyl cyclase,b ut markedly reduces signaling through b-arrestin. [4] Furthermore,the N131 3.35 Aa nd N131 3.35 Vm utants (superscripts indicate Ballesteros-Weinstein numbers [5] )o ft he d-opioid receptor constitutively activate b-arrestin-mediated signaling. [6] mOR signaling through the Gprotein and that through barrestin are responsible for its analgesic properties [7] and adverse effects, [8] respectively,a nd TRV130 reportedly increases analgesia and reduces on-target adverse effects versus morphine. [4, 9] Potential therapeutic applications of the functional selectivity of various GPCRs have also been proposed. [10] Therefore,the mechanisms underlying the functional selectivity of mOR are important for understanding the functions of GPCRs and for drug development.
Crystal structures of GPCRs in various forms have been solved, including GPCRs bound to inverse agonists and aG PCR bound to af ull agonist with aGprotein or aGprotein-mimicking nanobody [11] (see the Supporting Information). Furthermore,acrystal structure of rhodopsin bound to visual arrestin was recently reported. [12] However, this structure cannot explain the functional selectivity of the receptor, because the conformation of rhodopsin is almost identical to that in the crystal structure of rhodopsin bound to ap eptide variant of the Cterminus of G-transducin. [13] Therefore,w e utilized NMR spectroscopy to clarify the conformational equilibrium of mOR in the states bound to an antagonist, balanced agonists,and TRV130.
We prepared mORs with the sequences Gly54-Gln362 and Gly54-Pro400, both with the F158 3.41 Wm utation, in 2,2-didecylpropane-1,3-bis-b-d-maltopyranoside (LMNG) micelles and those reconstituted into the lipid bilayer of reconstituted high-density lipoproteins (rHDLs), [14, 15] also known as nanodiscs, [16] were prepared (see Figure S1 and details in the Supporting Information). Hereafter, the obtained mORs (Gly54-Gln362)/F158 3.41 Wa nd (Gly54-Pro400)/F158 3.41 Wa re referred to as mOR-A and mOR-A', respectively.T he obtained mOR retained binding activity to naloxone,morphine,D AMGO,and TRV130 (see Figures S2-S5 and details in the Supporting Information).
Our analysis of the G-protein and b-arrestin signaling efficacies of mOR bound to various ligands revealed that naloxone,m orphine,D AMGO,a nd TRV130 are the antagonist, balanced partial agonist, balanced full agonist, and Gprotein-biased partial agonist, respectively,against mOR with the F158 3.41 Wm utation, which was used in the NMR spectroscopic analysis,a nd that the N152 3.35 Am utant is a barrestin-biased mutant (Figure 1 ; see also Figure S6 and details in the Supporting Information). These results are in agreement with those from previous studies on mOR without the F158 3.41 Wmutation. [4, 17] mOR-A possesses 13 methionine residues in TM1-6, extracellular loop 2( ECL2), intracellular loop 1( ICL1), and ICL3 (see Figure S7) ,a nd M283 6 .36 exist on the intracellular side of TM3, 5, and 6, and the side chains of M163 3.46 and M283 6.36 are directed toward TM7. These methionine residues should be good probes to investigate the ligand-induced conformational changes,c onsidering that TM3, TM5, TM6, and TM7 assume distinctly different conformations upon GPCR activation. [11] In the 1 H- 13 Cm ethyl transverse relaxation-optimized spectroscopy (TROSY) spectra of [ab-2 H-,methyl-13 C-Met]mOR-A in LMNG micelles in the balanced-full-agonist (DAMGO)-bound and the antagonist (naloxone)-bound states,s everely overlapped resonances that apparently originated from the methionine residues were observed (see Figure S8 a,b) . To overcome the problem of signal overlap,w ei ntroduced mutations into the solvent-or lipid-exposed methionine residue (see Figure S9 a) . [18] Hereafter, we refer to the resulting M67 Hatoms,w eu tilized the recently developed deuteration method for proteins expressed in an insect-cellbaculovirus expression system [14] (see Figures S10-S12 and details in the Supporting Information). Hereafter, the obtained mOR-A/D6M mutant, in which eight types of amino acid residues (isoleucine,l eucine,p henylalanine, lysine,a rginine,t hreonine,v aline,a nd tyrosine residues) were deuterated, is referred to as [
, signals that apparently originated from the seven methionine residues of mOR-A/D6M were detected, thus suggesting that most of the methionine residues were observed (see Figure S8 c,d). Several methionine resonances were not clearly observed in the spectra of mOR-A/D6M without deuteration (see Figure S12 ), thus suggesting that the sensitivity for these resonances was increased more than threefold upon deuteration.
Assignments of the methionine resonances were established by comparison of the spectra of difference mutants (see To investigate the structures of the mOR TM region that elicits partially activated signaling,w er ecorded the 1 H-13 C methyl-TROSY spectra of [ 2 H-8AA, ab-2 H-,methyl- [19] To investigate the structures of the mOR TM region that elicits biased signaling,w er ecorded 1 H- 13 Cm ethyl-TROSY spectra of [ 5.49 in the balanced-full-agonist-bound state underwent conformational exchange,w er ecorded the spectra of mOR-A at the lower temperature of 283 K( see Figure S17 ). In this case,t he M245 5.49 resonance significantly shifted away from that for the G-protein-biased-partial-agonist-bound state.T hese results suggest that mOR exists in an equilibrium between multiple open conformations,i ncluding the conformations that preferentially activate either G-protein-mediated signaling or barrestin-mediated signaling,w ith faster exchange rates than the chemical-shift difference (> 100 s À1 ), and that the equilibrium is shifted toward the former and latter conformations in the G-protein-biased-ligand-bound state and the fullagonist-bound state of the b-arrestin-biased mutant, respectively. M163 3.46 ,M 257 5.61 ,a nd M283 6.36 exist in the intracellular side of TM3, TM5, and TM6 (see Figure S7) , and their chemical shifts would be sensitive to conformational changes of TM7, as well as TM3, TM5, and TM6 (see Figure S18 and details in the Supporting Information). Thechemical shifts of M283 6.36 indicate that the resonances observed in the antagonist-and full-agonist-bound states correspond to the closed and open conformations,r espectively (see the Supporting Information). Furthermore,t he chemical shifts of the M163 3.46 ,M 257 5.61 ,a nd M283 6 .36 signals in the balanced-fullagonist-bound state were also between those for the Gprotein-biased-partial-agonist-bound state and those for the full-agonist-bound state with the b-arrestin-biased mutation (Figure 3a ;s ee also Figures S19-S23 and details in the Supporting Information). Therefore,t he efficacy-and biasfactor-dependent conformational equilibrium observed for M245 5 .49 accompanies the coupled conformational changes on 
0.5 ,i n which d1 H (TRV130) and d13 C (TRV130) are the 1 Hand 13 Cchemical shifts in the TRV130-bound state, and d1 H (N152A)a nd d13 C (N152A) are the 1 Ha nd 13 Cchemical shifts of the b-arrestin-biased mutant in the DAMGO-bound state.
Angewandte
Chemie the intracellular side of TM3, TM5, TM6, and TM7 (Figure 3b) . Theb iased signaling of mOR by the coupled conformational changes on TM3, TM5, TM6, and TM7 is in contrast to the previously reported selective activation of Gprotein-and b-arrestin-mediated signaling by decoupled conformational changes of TM5/6 and TM3/7, respectively, in other GPCRs. [20, 21] It is possible that the intracellular cavity, which is formed in the crystal structure of GPCRs bound to af ull agonist with aG protein or G-protein-mimicking nanobody, [11] is relatively small in the conformation that preferentially activates b-arrestin signaling (see the Supporting Information).
On the basis of our structural interpretation of the Am utant, mOR adopts the open conformation, and the equilibrium between the multiple open conformations is shifted toward the conformations that preferentially activate b-arrestin-mediated signaling.T he dynamic characteristics of mOR are in agreement with the fast dynamics of another GPCR observed in recent solid-state NMR studies. [22] Thec onformational equilibrium that accompanies the coupled conformational change in TM3, TM5, TM6, and TM7 Figure 3 . Distribution of the methionine residues that exhibited chemical shifts in af unctional-selectivity-dependent manner. ,a nd M283 6.36 ,which exhibited chemical shifts in afunctional-selectivity-dependent manner (Figure 2b,c) , are depicted by red sticks. The other methionine residues and b-funaltrexamineare depicted by white and black sticks, respectively.TM3/7 and TM5/6 are colored cyan and light orange, respectively. . . upon the introduction of the b-arrestin-biased N152A mutation is in agreement with the structure-activity relationships of TRV130 derivatives (see Figure S24 and details in the Supporting Information). TRV130 reportedly produced greater analgesia than morphine,atdoses with less reduction in respiratory drive and diminished nausea in healthy human volunteers. [9] Therefore,observation of the population shift of the conformational equilibrium of mOR bound to various ligands,o nt he basis of the M245
5.49 resonances,w ould be helpful for the further development of analgesics with reduced side effects,better tolerance,and negligible dependence.
It is possible that the functional selectivity of other GPCRs is also regulated by the population shift of the conformational equilibrium that accompanies the coupled conformational changes of TM3, TM5, TM6, and TM7, as well as mOR (see the Supporting information). Therefore,the conformational equilibrium in the transmembrane region is important for understanding the functional selectivity of GPCRs.O bservation of the NMR signals of methionine residues,which are highly abundant in TM helices of GPCRs and can be observed without any chemical modification, [18] is applicable for the analysis of the conformational equilibrium that regulates biased signaling in various GPCRs.
In previous NMR studies of GPCRs,t he conformational changes of GPCRs induced by biased ligands or G-proteinmimicking nanobodies were observed by the use of 19 Fa nd 13 CH 3 probes chemically attached to cysteine and lysine residues,r espectively. [20, 23] In these studies,t he chemical probes could not be attached to residues in the middle of the transmembrane region owing to their solvent inaccessibility,a lthough the residues that are widely conserved and exhibit remarkable conformational changes upon activation, such as the P xxY motif,e xist in the middle of the transmembrane region. Furthermore,t here is ap ossibility that the probe would reflect the perturbation of the local conformation by the chemical modification. In contrast, methionine-selective labeling enabled the direct observation of the residues in the transmembrane region without any perturbation of the local conformation. [14, 18, 24] Deuteration also enabled the observation of the transmembrane region of mOR in the present study (see Figure S12 ), even at al ow mOR concentration (5-10 mm). Therefore,m ethionine-selective labeling, along with deuteration, should be useful for the analysis of the conformational dynamics of the transmembrane regions of GPCRs and other membrane proteins.
In this study,o ur NMR analysis of mOR in the balancedand biased-ligand-bound states revealed that the intracellular cavity of mOR exists in an equilibrium between closed and multiple open conformations,and that the population of each open conformation determines the G-protein-and b-arrestinmediated signaling levels in each ligand-bound state.T hese findings provide structural insight into the biased signaling of mOR and other GPCRs.
